Table 5.
Curamin mean ± SD | Placebo mean ± SD | Curamed mean ± SD | Intergroup comparison, mean difference or difference in rank sum$ and p values | ||
---|---|---|---|---|---|
Placebo vs Curamin | Placebo vs Curamed | ||||
Visit 1 Baselinea | 6.39 ± 3.47 N = 67 | 5.85 ± 3.25 N = 68 | 5.91 ± 2.77 N = 66 |
−0.53 P > 0.05 |
−0.06 P > 0.05 |
Visit 2a | 5.02 ± 3.46 N = 63 |
4.92 ± 3.09 N = 65 |
4.37 ± 2.88 N = 60 |
−0.08$ P > 0.05 |
8.252$ P > 0.05 |
Visit 3a | 4.49 ± 3.86 N = 61 | 5.22 ± 3.58 N = 59 | 3.84 ± 2.88 N = 58 |
0.73 P > 0.05 |
1.38 P > 0.05 |
Within group Comparisonb |
P < 0.0001 N = 61 |
P < 0.003 N = 59 |
P < 0.0001 N = 58 |
||
Effect Sizea d Cohen , g Hedges |
−0.519 | −0.185 | −0.734 | ||
Confidence interval | −0.872 − −0.166 | −0.534 − 0.165 | −1.098 − −0.369 | ||
Mean change from baseline to Visit 2a | 1.44 ± 1.98*** N = 63 |
0.89 ± 0.55** N = 65 |
1.47 ± 0.50*** N = 60 |
−0.55 P > 0.05 |
−0.02 −10.57$ P > 0.05 |
Mean change from baseline to Visit 3a | 2.02 ± 2.93*** N = 61 |
0.69 ± 2.70 N = 59 |
1.86 ± 2.95*** N = 58 |
−1.32
P < 0.05 |
−1.167
P > 0.05 |
Within group comparison:
aIntention to treat analysis of all patients - One sample matched-pair t-test or Wilcoxon non-parametric test, * - p < 0.05, ** - p < 0.01, *** - p < 0.001
bPatients completed all tests – repeated measures ANOVA
Between groups comparison: One-way. Independent- measures ANOVA with post hoc Dunnett’s Multiple Comparison Test or Kruskal-Wallis test with post hoc Dunns Test$
Effect size for mean differences of groups with different sample size; http://www.psychometrica.de/effect_size.html#anova. Confidence Coefficient – 95%